The global biotechnology market is expected to grow at a CAGR of 7% during 2013-2017 reaching sales worth nearly US$ 166 billion by 2017. This market, however, is expected to undergo a number of transformations which would impact the course of its growth. These transitions include a shift of growth from the developed to the emerging markets, an increasing focus on monoclonal antibodies compared to therapeutic proteins and an increasing penetration of biosimilars/follow-on-biologics compared to their branded versions. As a result of these transformations, the need for a user friendly, robust and comprehensive biotechnology market intelligence has become imperative for investors, researchers, consultants, marketing strategists, and all those who are planning to foray into the biotechnology market in some form or the other.
To know more about this report, please visit: www.imarcgroup.com/biotechnology-industry/
Be the change you want to see in the world!
Spread the love. Be the first to like this post!